| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18823986 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 102 journal articles in the PubMed database | Email to a friend | | |
| Laine L, Curtis SP, Langman M, et al.
Lower Gastrointestinal Events in a Double-Blind Trial of the Cyclo-Oxygenase-2 Selective Inhibitor Etoricoxib and the Traditional Nonsteroidal Anti-Inflammatory Drug Diclofenac. [JOURNAL ARTICLE]
Gastroenterology 2008 Aug 3.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Hunt RH, Harper S, Watson DJ, et al.
The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Am J Gastroenterol 2003 Aug; 98(8):1725-33.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Cannon CP, Curtis SP, FitzGerald GA, et al.
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. [Comparative Study, Journal Article, Research Support, Non-U.S. Gov't]
Lancet 2006 Nov 18; 368(9549):1771-81.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Chen YF, Jobanputra P, Barton P, et al.
Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. [Journal Article]
Health Technol Assess 2008 Apr; 12(11):1-178.
Abstract | Full Citation | | Laine L, Curtis SP, Cryer B, et al.
Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. [Comparative Study, Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't]
Lancet 2007 Feb 10; 369(9560):465-73.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Laine L, Connors LG, Reicin A, et al.
Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Gastroenterology 2003 Feb; 124(2):288-92.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Laine L, Bombardier C, Hawkey CJ, et al.
Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Gastroenterology 2002 Oct; 123(4):1006-12.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Cannon CP, Curtis SP, Bolognese JA, et al.
Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program: cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis. [Journal Article]
Am Heart J 2006 Aug; 152(2):237-45.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Ramey DR, Watson DJ, Yu C, et al.
The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysis. [Journal Article, Meta-Analysis]
Curr Med Res Opin 2005 May; 21(5):715-22.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
